Technical Analysis for VOQP - Vioquest Pharmaceutl

Grade Last Price % Change Price Change
grade D 0.009 0.00% 0.0000
VOQP closed unchanged on Tuesday, October 15, 2019, on 15 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A N/A Down
See historical VOQP trend table...

Date Alert Name Type % Chg
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Down Weakness 0.00%
Narrow Range Bar Range Contraction -10.00%
Wide Bands Range Expansion -10.00%
Gapped Down Weakness -10.00%
Narrow Range Bar Range Contraction -16.67%

Older signals for VOQP ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
VioQuest Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of clinical stage drug therapies for the treatment of oncology and infectious diseases. Its lead product includes Xyfid, which is under development for the treatment and prevention of hand-foot syndrome. The company's products also consist of VQD-002, a nucleoside analog that is in Phase I clinical trials for the treatment of cancer; and Lenocta, a small molecule inhibitor of various protein tyrosine phosphatases, which is in Phase IIa clinical trials for the treatment of melanoma, renal cell carcinoma, and other solid tumors. VioQuest Pharmaceuticals also provides chiral products, technology, and custom synthesis development services to pharmaceutical and fine chemical companies in various stages of a products' lifecycle. The company was founded in 2000 and is headquartered in Basking Ridge, New Jersey.
Medicine Cancer Clinical Medicine Biopharmaceutical Chemical Infectious Diseases Treatment Of Cancer Solid Tumors Cancer Treatments Melanoma Drug Therapies Targeted Therapy Merck Renal Cell Carcinoma Cyclacel Treatment Of Melanoma
Is VOQP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 0.265
52 Week Low 0.0006
Average Volume 19,170
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 0.0104
10-Day Moving Average 0.0093
Average True Range 0.0077
ADX 46.4
+DI 67.2828
-DI 25.4159
Chandelier Exit (Long, 3 ATRs ) -0.0031
Chandelier Exit (Short, 3 ATRs ) 0.0251
Upper Bollinger Band 0.0181
Lower Bollinger Band 0.0027
Percent B (%b) 0.41
BandWidth 148.076923
MACD Line -0.0012
MACD Signal Line -0.0014
MACD Histogram 0.0002
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0090
Resistance 3 (R3) 0.0090 0.0090 0.0090
Resistance 2 (R2) 0.0090 0.0090 0.0090 0.0090
Resistance 1 (R1) 0.0090 0.0090 0.0090 0.0090 0.0090
Pivot Point 0.0090 0.0090 0.0090 0.0090 0.0090
Support 1 (S1) 0.0090 0.0090 0.0090 0.0090 0.0090
Support 2 (S2) 0.0090 0.0090 0.0090 0.0090
Support 3 (S3) 0.0090 0.0090 0.0090
Support 4 (S4) 0.0090